Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...
WuXi Biologics (WuXi Bio) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), ...
Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...
The “Integrated Spatial Planning Formulation and Sustainable Development Ordinance,” enacted on 26 November last year, aims ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the QTORIN™ platform, in development for serious, rare skin diseases and vascul ...
HUZHOU CITY, ZHEJIANG PROVINCE, CHINA, March 16, 2026 /EINPresswire.com/ -- The UV paint market has seen steady growth ...
BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
UPL restructuring will establish a new listed company - UPL Global - combining India and international crop protection businesses. UPL Global is expected to become one of the largest listed crop ...
Chief Executive John Lee says the Hong Kong Special Administrative Region Government will proactively align with the National 15th Five-Year Plan and press ahead with high-quality development.
The Chinese biotech put the idea to the test in a phase 2 trial of a subcutaneous depot formulation of its GLP-1 receptor agonist ASC30. U.S. investigators randomized 65 people with obesity or who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results